These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9734654)

  • 21. Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations.
    Pilz G; Fraunberger P; Appel R; Kreuzer E; Werdan K; Walli A; Seidel D
    Crit Care Med; 1996 Apr; 24(4):596-600. PubMed ID: 8612409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function.
    Díez JJ; Hernanz A; Medina S; Bayón C; Iglesias P
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):515-21. PubMed ID: 12354134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of TNF alpha and its p55 soluble receptor in malignant lymphomas.
    Warzocha K; Salles G; Bienvenu J; Barbier Y; Bastion Y; Doche C; Rieux C; Coiffier B
    Leukemia; 1997 Apr; 11 Suppl 3():441-3. PubMed ID: 9209418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma.
    Brenne AT; Romstad LH; Gimsing P; Juliusson G; Turesson I; Romundstad P; Borset M; Sundan A; Waage A
    Haematologica; 2004 May; 89(5):552-6. PubMed ID: 15136218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury.
    Maier B; Lehnert M; Laurer HL; Mautes AE; Steudel WI; Marzi I
    Shock; 2006 Aug; 26(2):122-7. PubMed ID: 16878018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis.
    Gattorno M; Picco P; Buoncompagni A; Stalla F; Facchetti P; Sormani MP; Pistoia V
    Ann Rheum Dis; 1996 Apr; 55(4):243-7. PubMed ID: 8733441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of tumor necrosis factor (TNF) receptors p55 and p75 in TNF responses of acute myeloid leukemia blasts in vitro.
    Delwel R; van Buitenen C; Löwenberg B; Touw I
    Blood; 1992 Oct; 80(7):1798-803. PubMed ID: 1382704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble tumor necrosis factor receptors in sera from patients with insulin-dependent diabetes mellitus: relations to duration and complications of disease.
    Kulseng B; Vatten L; Espevik T
    Acta Diabetol; 1999 Jun; 36(1-2):99-105. PubMed ID: 10436260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value for survival of soluble tumor necrosis factor receptors p55 and p75 during zidovudine-containing treatment in symptomatic human immunodeficiency virus type 1 infection.
    Frissen PH; Weverling GJ; Endert E; Jansen J; Sauerwein HP; Lange JM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):482-8. PubMed ID: 8757425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.
    van der Poll T; Jansen J; van Leenen D; von der Möhlen M; Levi M; ten Cate H; Gallati H; ten Cate JW; van Deventer SJ
    J Infect Dis; 1993 Oct; 168(4):955-60. PubMed ID: 8397270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation.
    Peschon JJ; Torrance DS; Stocking KL; Glaccum MB; Otten C; Willis CR; Charrier K; Morrissey PJ; Ware CB; Mohler KM
    J Immunol; 1998 Jan; 160(2):943-52. PubMed ID: 9551933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p55 and p75 tumor necrosis factor receptors in patients with chronic lymphocytic leukemia.
    Waage A; Liabakk N; Lien E; Lamvik J; Espevik T
    Blood; 1992 Nov; 80(10):2577-83. PubMed ID: 1384790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergent roles for p55 and p75 TNF-alpha receptors in the induction of plasminogen activator inhibitor-1.
    Pandey M; Tuncman G; Hotamisligil GS; Samad F
    Am J Pathol; 2003 Mar; 162(3):933-41. PubMed ID: 12598326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-4, interleukin-10, and soluble tumor necrosis factor receptors in cord blood.
    Hata T; Kawamura T; Fujiwaki R; Aoki S; Hata K; Inada K
    Gynecol Obstet Invest; 1997; 43(3):155-7. PubMed ID: 9127126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in patients with cervical cancer.
    Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Prontera C; Facchini V; Genazzani A
    Oncol Rep; 1996 Sep; 3(5):891-4. PubMed ID: 21594476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: a possible mechanism of enhanced TNF activity.
    Steinshamn S; Bemelmans MH; Buurman WA; Waage A
    Cytokine; 1995 Jan; 7(1):50-6. PubMed ID: 7749066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
    Jablońska E; Kiluk M; Piotrowski L; Grabowska Z; Markiewicz W; Jablonski J
    Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients.
    Salles G; Bienvenu J; Bastion Y; Barbier Y; Doche C; Warzocha K; Gutowski MC; Rieux C; Coiffier B
    Br J Haematol; 1996 May; 93(2):352-9. PubMed ID: 8639428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sources of alveolar soluble TNF receptors during acute lung injury of different etiologies.
    Dorr AD; Wilson MR; Wakabayashi K; Waite AC; Patel BV; van Rooijen N; O'Dea KP; Takata M
    J Appl Physiol (1985); 2011 Jul; 111(1):177-84. PubMed ID: 21512145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.